Key result
Preoperative acute hyperglycemia is linked to ~26% higher risk of 1-year adverse cardiac events.
Why the study?
The association between preoperative acute hyperglycemia and postoperative adverse cardiac events after non-cardiac surgery was uncertain and warranted evaluation.
Does preoperative acute hyperglycemia increase adverse cardiac events in adult patients undergoing non-cardiac surgery?
Cohort (n=111,110)
Yes
Does preoperative acute hyperglycemia increase adverse cardiac events in adult patients undergoing non-cardiac surgery?
Hazard Ratio: 1.26 (95% CI 1.16–1.36)
Absolute Event Rate: 2.7% vs 2.2%
p-value: p=<0.001
Preoperative acute hyperglycemia is independently associated with an increased risk of adverse cardiac events within one year after non-cardiac surgery, particularly in younger and non-hypertensive patients.
Supports preoperative glucose assessment for risk stratification; hypothesis-generating and should not yet change practice.
BACKGROUND: We conducted a multicenter cohort study to evaluate whether preoperative acute hyperglycemia is associated with postoperative adverse cardiac events. METHODS: Data from 10 hospitals were converted to the Observational Medical Outcomes Partnership Common Data Model and analyzed. We extracted the records of 318 119 adult patients who underwent non-cardiac surgery and had available blood glucose measurements less than 24 h before surgery. We defined acute hyperglycemia as at least one fasting blood glucose measurement > 140 mg/dl or random blood glucose level measurement > 180 mg/dl < 24 h before surgery. Risk of adverse cardiac events during the first year after surgery was analyzed. RESULTS: After 1:2 propensity score matching (PSM), 40 340 patients with acute hyperglycemia and 70 770 patients without hyperglycemia were enrolled. Acute hyperglycemia was associated with an increased risk of adverse cardiac events (hazard ratio [HR], 1.26; 95% CI, 1.16-1.36; P < 0.001). In the subgroup analyses, the young age group (≤ 65 years) had a significantly higher risk (HR, 1.61; 95% CI, 1.40-1.85) than the older age group (HR, 1.13; 95% CI, 1.03-1.25; P for interaction < 0.001). A greater adverse cardiac events risk was observed in patients without hypertension (HR, 1.37; 95% CI, 1.24-1.52) but not in those with hypertension (HR, 1.09; 95% CI, 0.96-1.22; P for interaction = 0.003). CONCLUSIONS: Preoperative acute hyperglycemia was associated with adverse cardiac events during one year of follow up. Further investigation is warranted to determine whether acute glycemic control before non-cardiac surgery could prevent perioperative cardiac complications.
No takes yet. Share an insight, caveat, or question.
Choi et al. (2025) conducted a cohort in Non-cardiac surgery (n=111,110). Preoperative acute hyperglycemia vs. Normoglycemia was evaluated on Adverse cardiac events within one year after surgery (HR 1.26, 95% CI 1.16-1.36, p=<0.001). Preoperative acute hyperglycemia was associated with a significantly increased risk of adverse cardiac events within one year after non-cardiac surgery compared to normoglycemia (HR 1.26).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: